Eli Lilly (NYSE: LLY) has achieved a major milestone by securing regulatory approval for its weight management drug, Mounjaro, in China ... loss drug, Wegovy. The timing of Mounjaro’s approval ...

Bloomberg. "Lilly's Weight-Loss Drug Approved in China Amid Race With Novo." Reuters. “Eli Lilly's weight loss drug tirzepatide gets approval in China.” JAMA Internal Medicine. "Semaglutide vs ...

Eli Lilly & Co.’s Mounjaro gained Chinese regulatory approval for weight less than a month after a similar therapy from Novo Nordisk A/S, fueling competition in a nation that’s among the world ...

On Friday, China’s National Medical Products Administration (NMPA) approved Eli Lilly And Co (NYSE ... Mounjaro for diabetes and Zepbound for weight loss. Related: Chinese Generic Ozempic ...

SHANGHAI (Reuters) -Eli Lilly said in a social media post Friday its weight loss drug tirzepatide had received approval from Chinese regulators, further intensifying competition with its Danish ...

Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest ... with Eli Lilly, which secured approval for its weight-loss drug in China in ...

The group faces competition from rival Eli Lilly, whose diabetes drug tirzepatide received approval from China in May. Some analysts expect Zepound, the U.S. firm’s weight-loss drug with the ...

The market for weight-loss drugs could see new entrants among existing biotech firms, with several drug candidates ... on Asia’s obesity market will grow, particularly in China and Japan ...

A new obesity drug co-developed by China’s Innovent Biologics Inc. and Eli Lilly & Co. has demonstrated significant weight loss in a late stage trial, paving the way for its approval in the ...

Eli Lilly announced on its WeChat account Friday that it has won approval from Chinese regulators to sell tirzepatide for weight loss in the country. Tirzepatide is the active ingredient in Lilly ...

SHANGHAI, July 19 (Reuters) - Eli Lilly (LLY.N), opens new tab said in a social media post, opens new tab Friday its weight loss drug tirzepatide had received approval from Chinese regulators ...

SHANGHAI (Reuters) -Novo Nordisk's hugely popular weight-loss drug Wegovy has been approved in China, it said on Tuesday, the world's second-largest economy and the country estimated to hold the ...